TEAM, INC. Announces $150 Million ATM Equity Offering Program
Nov 28, 2016 13:16 pm UTC| Business
SUGAR LAND, Texas, Nov. 28, 2016 -- Team, Inc. (NYSE:TISI) (“Team” or the “Company”) today announced that it has filed a prospectus supplement under which it may sell up to $150,000,000 of its common stock through an...
TDC Group and Nokia increase Danish broadband speeds to deliver better customer experience
Nov 28, 2016 13:08 pm UTC| Business
Press Release TDC Group doubles copper broadband network speeds with addition of Vplus technology to existing VDSL2 vectoring networkThis supports TDC Groups aim to deliver the best connections to Danes, and offer new...
Newgioco Group Files 2016 Third Quarter Results on Form 10-Q
Nov 28, 2016 13:00 pm UTC| Business
NEW YORK, Nov. 28, 2016 -- Newgioco Group, Inc. (OTCQB:EMGL) a company providing regulated online and offline gaming and wagering through licensed subsidiaries in Italy, announced today that it has filed its 2016 third...
Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2016 Financial Results
Nov 28, 2016 13:00 pm UTC| Business
TEL AVIV, Israel, Nov. 28, 2016 -- Cellect Biotechnology Ltd. (NASDAQ:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and...
CymaBay Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 28, 2016 13:00 pm UTC| Business
NEWARK, Calif., Nov. 28, 2016 -- CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and...
Nov 28, 2016 13:00 pm UTC| Business
SEATTLE, Nov. 28, 2016 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that the Company strengthened its leadership team with the appointment of Monique M....
Nov 28, 2016 13:00 pm UTC| Business
BOTHELL, Wash., Nov. 28, 2016 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced the initiation of PROMISE 2...